SCHEMBL28049210

SCHEMBL28049210

NC(=O)c1nccnc1-c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 3/20 0.40
IDO1 P14902 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
IKBKB O14920 2/20 0.39
CHUK O15111 2/20 0.39
CDC7 O00311 1/20 0.39
MAPK13 O15264 1/20 0.39
RAF1 P04049 1/20 0.39
MAPK9 P45984 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1966662 0.84 BCL2L1 (0.47) PDE3BPDE3AMAPK13MAPK12MAPK11
SCHEMBL3468178 0.81 ADORA2A (0.50) IKBKBCDC7CYP3A4CYP2C19LMNA
SCHEMBL21722362 0.80 HPGDS (0.51) CDC7MAPK9MAPK1CYP1A2CYP3A4
SCHEMBL6747759 0.79 PARP10 (0.40) IDO1LMNA
SCHEMBL22290171 0.78 LMNA (0.50) IKBKBMAPK13MAPK12MAPK11MAPK14
SCHEMBL28982335 0.77 PTGS2 (0.49) IKBKBCHUKMAPK9CA9CA12
SCHEMBL4763130 0.77 KMO (0.44) CDC7MAPK13MAPK9MAPK12MAPK11
SCHEMBL28225056 0.76 PARP1 (0.47) IKBKBCHUKCDC7MAPK14CA1
SCHEMBL18076050 0.76 MKNK1 (0.55) IKBKBCHUKGRM2
SCHEMBL30108258 0.76 PARP1 (0.47) IKBKBCHUKCDC7MAPK14CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102665718-B Heterocyclic compounds useful as PDK1 inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2016-03-09 CN disclosed